3D Scanning as an Advanced Tool for Identifying Tooth Lesions in Children
Launched by INDIANA UNIVERSITY · Feb 14, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well a new 3D scanning tool can help identify dental problems in children, specifically issues like tooth decay, wear, and discoloration. Researchers want to see if this advanced scanning method is effective compared to traditional visual checks done by dentists. They will examine children aged 3 to 12 years who have at least one fully grown baby tooth during their dental appointment at Indiana University School of Dentistry.
If eligible, your child will go through a quick dental check that includes both a visual exam and a 3D scan, which should take about 30 minutes. It's important to note that children with certain conditions, such as those with unerupted or restored teeth, or those on medication, cannot participate. This study is not yet recruiting participants, but it aims to help improve how we detect and treat dental issues in young children.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged between 3 and 12 years old, presenting at least one fully erupted primary tooth.
- Exclusion Criteria:
- • Unerupted primary teeth.
- • Restored teeth.
- • Children under 3 or older than 12 years old.
- • Children using medication.
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Patients applied
Trial Officials
Aline Castilho, DDS
Principal Investigator
Indiana Unviersity
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported